These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 11086282

  • 41. [Amoxicillin/clavulanic acid (875/125 mg). New pharmacodynamic aspects].
    Lode H.
    Dtsch Med Wochenschr; 1999 Dec 03; 124(48):1459-61. PubMed ID: 10615328
    [No Abstract] [Full Text] [Related]

  • 42. Elements of design: the knowledge on which we build.
    MacGowan AP.
    Clin Microbiol Infect; 2004 Apr 03; 10 Suppl 2():6-11. PubMed ID: 14759228
    [Abstract] [Full Text] [Related]

  • 43. [Activity of cefpodoxime and other oral beta-lactams against Haemophilus influenzae and Streptococcus pneumoniae with different susceptibilities to penicillin].
    Fenoll A, Robledo O, Lerma M, Giménez MJ, Cebrián L, Casal J, Aguilar L, Gómez-Lus ML.
    Rev Esp Quimioter; 2006 Mar 03; 19(1):39-44. PubMed ID: 16688290
    [Abstract] [Full Text] [Related]

  • 44. AUC(0-t)/MIC is a continuous index of fluoroquinolone exposure and predictive of antibacterial response for Streptococcus pneumoniae in an in vitro infection model.
    Zelenitsky SA, Ariano RE, Iacovides H, Sun S, Harding GK.
    J Antimicrob Chemother; 2003 Apr 03; 51(4):905-11. PubMed ID: 12654762
    [Abstract] [Full Text] [Related]

  • 45. Bactericidal activity and postantibiotic effect of cefdinir (Cl 983, FK 482) against selected pathogens.
    Blandino G, Caccamo F, Di Marco R, Nicoletti A, Speciale A, Nicoletti G.
    Drugs Exp Clin Res; 1992 Apr 03; 18(8):319-27. PubMed ID: 1292914
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach.
    González N, Aguilar L, Alou L, Giménez MJ, Sevillano D, Torrico M, Cafini F, Coronel P, Prieto J.
    J Antimicrob Chemother; 2009 Jun 03; 63(6):1215-22. PubMed ID: 19307171
    [Abstract] [Full Text] [Related]

  • 48. Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate.
    File TM, Jacobs MR, Poole MD, Wynne B, 546, 547, 548, 549, 550, 551, 556, 557 and 592 Clinical Study Groups.
    Int J Antimicrob Agents; 2002 Oct 03; 20(4):235-47. PubMed ID: 12385678
    [Abstract] [Full Text] [Related]

  • 49. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E, Dalhoff A, Korfmann G.
    Int J Antimicrob Agents; 2009 Jan 03; 33(1):52-7. PubMed ID: 18835763
    [Abstract] [Full Text] [Related]

  • 50. Penicillin-resistant Streptococcus pneumoniae in Lebanon: the first nationwide study.
    Uwaydah M, Mokhbat JE, Karam-Sarkis D, Baroud-Nassif R, Rohban T.
    Int J Antimicrob Agents; 2006 Mar 03; 27(3):242-6. PubMed ID: 16464561
    [Abstract] [Full Text] [Related]

  • 51. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
    Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN, Alexander Project Group.
    J Antimicrob Chemother; 2003 Aug 03; 52(2):229-46. PubMed ID: 12865398
    [Abstract] [Full Text] [Related]

  • 52. Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
    Zhanel GG, Yachison C, Nichol K, Adam H, Noreddin AM, Hoban DJ, Karlowsky JA.
    J Antimicrob Chemother; 2012 Jul 03; 67(7):1706-11. PubMed ID: 22467630
    [Abstract] [Full Text] [Related]

  • 53. Exacerbation of COPD: amoxicillin + clavulanic acid in vitro activity vs S. pneumoniae, H. influenzae and M. catarrhalis.
    Beghi G, Legnani D, De Bartolo A, Pagani N, Lusco G.
    J Chemother; 1995 Nov 03; 7 Suppl 4():61-2. PubMed ID: 8904109
    [No Abstract] [Full Text] [Related]

  • 54. A pharmacodynamic model to support a 12-hour dosing interval for amoxicillin/sulbactam, a novel oral combination, in the treatment of community-acquired lower respiratory tract infections.
    Bantar C, Nicola F, Fernandez Canigia L, Arenoso HJ, Soutric J, Montoto M, Blanco M, Smayevsky J, Jasovich A.
    J Chemother; 2000 Jun 03; 12(3):223-7. PubMed ID: 10877517
    [Abstract] [Full Text] [Related]

  • 55. In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations.
    Andes D, Craig WA.
    Antimicrob Agents Chemother; 1998 Sep 03; 42(9):2375-9. PubMed ID: 9736566
    [Abstract] [Full Text] [Related]

  • 56. Performance in practice: bacteriological efficacy in patients with drug-resistant S. pneumoniae.
    Garau J.
    Clin Microbiol Infect; 2004 Apr 03; 10 Suppl 2():28-35. PubMed ID: 14759231
    [Abstract] [Full Text] [Related]

  • 57. [Study of the bactericide activity of the combination amoxycillin/clavulanic acid and its possible effects in the resistance of beta-lactam drugs].
    Prieto J, Frías J, Alou L, Carcas A.
    Med Clin (Barc); 1998 Feb 03; 110 Suppl 1():12-5. PubMed ID: 9717154
    [No Abstract] [Full Text] [Related]

  • 58. Building in efficacy: developing solutions to combat drug-resistant S. pneumoniae.
    Jacobs MR.
    Clin Microbiol Infect; 2004 Apr 03; 10 Suppl 2():18-27. PubMed ID: 14759230
    [Abstract] [Full Text] [Related]

  • 59. In vivo activity of amoxicillin/clavulanic acid and erythromycin in experimental otitis media caused by Streptococcus pneumoniae plus Haemophilus influenzae.
    Parra A, Ponte C, Cenjor C, García-Olmos M, Giménez MJ, Aguilar L, Soriano F.
    Int J Antimicrob Agents; 2004 Jan 03; 23(1):25-31. PubMed ID: 14732310
    [Abstract] [Full Text] [Related]

  • 60. [Bactericidal effect of cefadroxil, amoxicillin alone or in combination with clavulanic acid in sera of healthy volunteers].
    Etesse-Carsenti H, Garraffo R, Bernard E, de Salvador F, Pradier C, Durant J, Mondain V, Drugeon HB, Dellamonica P.
    Pathol Biol (Paris); 1991 Dec 03; 39(10):972-7. PubMed ID: 1805138
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.